Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

08 juil. 2013 07h00 HE | Source: Response Genetics, Inc.

Response Genetics, Inc. Announces Contract With Blue Cross and Blue Shield of Illinois

LOS ANGELES, July 8, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...
04 juin 2013 07h00 HE | Source: Response Genetics, Inc.

Response Genetics Achieves Milestone Payments Totaling $1,000,000 for Services Provided to GlaxoSmithKline in the Development of BRAF-Inhibitor Tafinlar(R) (dabrafenib)

LOS ANGELES, June 4, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...
20 mai 2013 07h00 HE | Source: Response Genetics, Inc.

Response Genetics, Inc. Announces Presentations at the American Society of Clinical Oncology 2013 Annual Meeting

LOS ANGELES, May 20, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...
16 mai 2013 07h00 HE | Source: Response Genetics, Inc.

Response Genetics, Inc. Announces Contract With Blue Shield of California

LOS ANGELES, May 16, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's...
14 mai 2013 07h00 HE | Source: Response Genetics, Inc.

Response Genetics, Inc. Announces First Quarter 2013 Financial Results

Q1 Revenue Increases Over 40% to $5.6 Million Relative to Q1 2012 and Gross Margin Increases to 55% First Quarter Losses decrease to $0.8 million relative to Q1 2012 loss of $3.1 million LOS...
08 mai 2013 07h00 HE | Source: Response Genetics, Inc.

Response Genetics to Present at the 2013 UBS Global Healthcare Conference

LOS ANGELES, May 8, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's response...
06 mai 2013 07h00 HE | Source: Response Genetics, Inc.

Response Genetics, Inc. to Release First Quarter 2013 Financial Results and Host Conference Call on May 14, 2013

LOS ANGELES, May 6, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's response...
21 mars 2013 07h00 HE | Source: Response Genetics, Inc.

Response Genetics, Inc. Announces Fourth Quarter and Year-End 2012 Financial Results

--- Q4 Revenue Increases 11% to $5.5 Million Relative to Q4 2011 and Gross Margin Increases to 54% --- --- Fourth Quarter Losses Decrease to $0.5 Million Relative to Q4 2011 Loss of $3.9 Million...
12 mars 2013 07h00 HE | Source: Response Genetics, Inc.

Response Genetics to Present at the 25th Annual ROTH Conference

LOS ANGELES, March 12, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests for cancer, announced today that...
07 mars 2013 07h00 HE | Source: Response Genetics, Inc.

Response Genetics, Inc. to Release Fourth Quarter and Year-End 2012 Financial Results and Host Conference Call on March 21, 2013

LOS ANGELES, March 7, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and commercialization of molecular diagnostic tests for cancer, will announce...

Page précédente